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Abstract 12 
The identification of biomarkers through Mass spectrometry imaging (MSI) is gaining 13 
popularity in the clinical field. However, considering the complexity of spectral and spatial 14 
variables faced, data mining of the hyperspectral images can be troublesome. The discovery 15 
of markers generally depends on the creation of classification models which should be 16 
validated to ensure the statistical significance of the discriminants m/z detected. Internal 17 
validation using resampling methods such as cross validation (CV) are widely used for model 18 
selection, the estimation of its generalization performance and biomarker discovery when 19 
sample sizes are limited and an independent test set is not available. Here, we introduce for 20 
first time the use of Constrained Repeated Random Subsampling CV (CORRS-CV) on multi-21 
images for the validation of classification models on MSI. Although several aspects must be 22 
taken into account (e.g. image size, CORRS-CV∂value, the similarity across spatially close 23 
pixels, the total computation time), CORRS-CV provides more accurate estimates of the 24 
model performance than k-fold CV using of biological replicates to define the data split when 25 
the number of biological replicates is scarce and holding images back for testing is a waste of 26 
valuable information. Besides, the combined use of CORRS-CV and rank products increases 27 
the robustness of the selection of discriminant features as candidate biomarkers which is an 28 
important issue due to the increased biological, environmental and technical variabilities 29 
when analysing multiple images, especially from human tissues collected in clinical studies. 30 
 31 
Keywords. mass spectrometry imaging (MSI); cross validation (CV); constrained repeated 32 
random sampling - cross validation (CORRSCV) ; partial least squares-discriminant analysis 33 




1. INTRODUCTION 37 
Mass spectrometry imaging (MSI) is a powerful technique that acquire high dimensional 38 
mass spectra at known spatial points of a sample, providing quantitative information of the 39 
spatial (i.e. morphological) distribution of organic compounds such as proteins, peptides, 40 
lipids, drugs or metabolites in biological tissues. MSI is becoming an established tool in 41 
clinical and pharmaceutical research that might be soon be introduced into clinical practice 42 
thanks, at least partially, to technological advances in the development of novel ambient 43 
ionization techniques and MS instrumentation allows MSI with minimal sample preparation 44 
[1][2][3].  45 
MSI generates large, complex datasets that require advanced high-throughput data 46 
processing and data mining techniques for a thorough biological analysis. Two of the main 47 
objectives of MSI data analysis are segmentation and classification. Segmentation aims at 48 
the unsupervised identification of pixels with characteristic spectral profiles. Classification 49 
aims at assigning pixels to pre-defined classes (e.g. control or disease) or to get further 50 
insight of underlying biochemical differences based on known information provided by a 51 
reference method such as pathological examination, thus facilitating the identification and 52 
interpretation of clinical biomarkers or the development of classifiers[4]. Segmentation is 53 
usually carried out using multivariate unsupervised methods that do not require a priori 54 
information or foreknowledge of the classes of the pixels and aim at revealing general data 55 
structure. Many methods have been exploited such as principal component analysis or 56 
clustering methods, including hierarchical, K-means, fuzzy k-means, and spatially aware data 57 
clustering [4][5]. Alternatively, classification requires a supervised analysis across 58 
comparable histological areas which is usually based on univariate tests (e.g. t-test, one-way 59 
ANOVA, Wilcoxon rank sum test), fold changes or on multivariate strategies such as linear 60 
discriminant analysis, partial least squares discriminant analysis (PLSDA), principal 61 
component discriminant analysis or support vector machines[2][4][6][7][8]. 62 
A critical step in the development of any classifier is the assessment of its generalization 63 
performance to estimate its prediction accuracy beyond the training data[9]. Besides, this 64 
step also supports the identification of discriminant MS features, prior to biomarker 65 
interpretation. Considering the large number of m/z on MS spectra, a significant challenge of 66 
MSI is the large data volume of the images generated. Its introduction into clinical practice 67 
would likely lead to an exponential growth in the computational requirements. Therefore, 68 
the development of algorithms for biomarker selection might contribute to reduce the data 69 
volume while improving the quality of the information retrieved, which will facilitate the 70 
development of hardware and software to meet the demand for automated image analysis. 71 
Model development in an ideal situation involves the split of the MSI data set into three 72 
subsets: a training set to fit the models, a validation set to select the optimal model (i.e. 73 
selection of algorithm parameters that are not directly estimated from the data such as the 74 
number of latent variables (LVs) in PLS-DA) and a test set to estimate its predictive accuracy. 75 
Train, validation and test subsets should be independent, representative of the whole 76 
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population and include all sources of technical and biological variation[10]. However, if the 77 
total number of samples is small, this strategy may not be a feasible solution. In these 78 
situations, internal validation using resampling methods such as cross validation (CV) are 79 
commonly used for model selection and the estimation of its generalization performance.  80 
K-fold CV is one of the most widely used methods for CV. During k-fold CV, the set of N 81 
objects (e.g. pixels or images) is split into k mutually exclusive subsets of size N/k. Then, k-1 82 
subsets are used as training set to fit a model, which is used to predict the left-out validation 83 
subset. The process is repeated k times, each time excluding a different validation subset 84 
and then, an estimate of the model performance is calculated from the predicted values. 85 
Therefore, each pixel is included in a validation set once and k-1 times in the training sets. 86 
Lower k values typically lead to estimates of prediction error biased upward and higher k 87 
values minimize bias but increase variance[11].  88 
As a general rule, CV data split should be done at the highest level of the sampling hierarchy 89 
and based e.g. on biological replicates, rather than technical replicates or individual 90 
pixels[12],[13]. However, this approach may be impractical if the number of images from 91 
independent biological sources is scarce. As a suboptimal alternative, the dataset can be 92 
randomly split into k equally sized folds. However, a selection of the k subsets completely at 93 
random results in a loss of spatial structure and pixel-neighbourhood information and 94 
spatially proximate pixels are distributed simultaneously into train and validation sets, 95 
leading to a situation resembling to the replicate trap and providing overly optimistic 96 
classification accuracy estimates.  97 
In order to overcome this potential pitfall, a straightforward CV strategy, namely constrained 98 
repeated random subsampling – cross validation (CORRS-CV) has been recently 99 
proposed[11] and evaluated for the assessment of PLS-DA models of single infrared 100 
hyperspectral images where it avoided the optimistic effect of spectral oversampling. 101 
CORRS-CV is based on the random generation of training and test sub-sets using a 102 
constrained random sampling of training pixels without replacement. The constrained 103 
sampling ensures that the Euclidean distance among train pixels and between the test and 104 
train pixels is higher than a user defined threshold (∂). After completing the training set 105 
selection, random repeated k-fold CV is used for model selection and optimization. In this 106 
inner k-fold CV, CORRS-CV also ensures that the distance among train and validation pixels is 107 
higher than ∂. Then, pixels included in the test set are used to estimate of the prediction 108 
accuracy of the trained model. The process of training set selection and model optimization 109 
is iterated to average the impact of the random selection of the train and test subsets. At the 110 
end of the process, a set of predicted values for each pixel is obtained which enables a 111 
better estimate of the class than a single prediction[14] and can be used to assess the 112 
performance of the classification models and to build class-predicted pseudo-image.  113 
The objective of this study was to extend the application of CORSS-CV to MSI and to the 114 
discovery of biomarkers during the simultaneous analysis of multiple images obtained from 115 
different patients, a frequent scenario in biomarker discovery studies. This required the 116 
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adaptation of the CORSS-CV algorithm to multi-images, where boundaries of each image 117 
should be considered. Using the human renal cell carcinoma (RCC) data set[15] as 118 
benchmark,  the use of biological replicates to define a k-fold CV split provided an accurate 119 
estimation of the generalization performance, but it was found inefficient when the number 120 
of biological replicates was scarce. We also evaluated different factors affecting the 121 
implementation of CORSSCV such as the images size, the∂value, the similarity across 122 
spatially close pixels and the total computation time. In situations where holding images 123 
back for testing compromises the performance of the analysis, CORRS-CV provided accurate 124 
and more robust figures of merit. Besides, information extracted from the iterative 125 
development of discriminant models during CORRS-CV enabled a straightforward selection 126 
of discriminant biomarkers.  127 
 128 
2. MATERIAL AND METHODS 129 
MSI data 130 
The RCC data set[15] is a relatively small MSI data set that consists of eight matched pairs of 131 
human kidney tissue (i.e. 16 images) including 6077 pixels (i.e. MS spectra) classified as 132 
cancer (2775 pixels) or normal (3302 pixels) by a pathologist. Each biological replicate 133 
consists of a normal tissue and a cancerous tissue samples with different absolute and 134 
relative pixel sizes (see Table 1).  135 
Initial data pre-processing was carried out using Cardinal[13] and included total ion count 136 
standardization for pixel intensity normalization, and resampling to unit resolution.   137 
Constrained repeated random sampling - cross validation (CORRS-CV) for multi-images. 138 
CORRS-CV is based on the repeated split of the image into training and test subsets following 139 
a constrained random sampling of n training pixels without replacement[11]. Initially, a pixel 140 
is randomly sampled and included in the training set. Then, those pixels in the same image at 141 
a distance lower than a given threshold (∂) from the selected pixel are excluded from the 142 
set of pixels suitable to be included in the training set. The process is repeated until n pixels 143 
have been included in the training set, and the test set is defined as the remaining set of 144 
pixels which were not included in the training set or excluded because of its closeness to a 145 
train pixel. The training set is used for the development of a discriminant model, which is 146 
applied for the prediction of the test set and calculation of AUROC value. Model selection is 147 
based on a repeated random k-fold CV of the training set, using the maximum mean 148 
classification accuracy as objective function. The whole process of selection of train and test 149 
sets, model development and test set prediction is repeated until a user defined value (In 150 
this study >99%) pixels have been included least once in a test set and a training set. The 151 
number of required iterations depends on the training set and image sizes and the selected 152 
∂. Finally, a mean estimate of the AUROC values obtained after each iteration is calculated. 153 
In this work, PLS-DA was used as a classifier and the AUROC was selected as figure of merit 154 
for this binary classification. The number of LVs was selected considering the minimum mean 155 
classification accuracy of the inner k-fold cross validation, considering a maximum of 15 (see 156 
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[10] for more information). The AUROC was selected because it does not depend on the 157 
prior class distribution and so, it facilitates comparing outcomes from data sets with 158 
different class distributions[16]. Five iterations of random 5-fold CV was used for CV of the 159 
inner PLS-DA models. 160 
Software 161 
Initial data pre-processing was carried out using Cardinal (Release 3.8) [13] in R 3.5.1[17]. 162 
Further data analysis was carried out in MATLAB 2017b (Mathworks Inc., Natick, MA, USA) 163 
using in-house written scripts and the PLS Toolbox 8.7 (Eigenvector Research Inc., 164 
Wenatchee, USA). Calculations were carried out employing a standard laptop computer with 165 
Intel® Core i5 processor operating at 2.4 GHz. The MATLAB function used in this work for 166 
CORRSCV for multi-images (corrscv_msi.m) is available as supplementary material. 167 
 168 
3. RESULTS AND DISCUSSION 169 
Three strategies for CV were compared for the assessment of the discrimination of cancer 170 
and normal tissues and feature selection in the RCC data set. The first strategy involved a 171 
repeated (n=5) random split of the data set into k=5 folds (i.e. 5 iterations, 5-fold CV) for the 172 
purpose of illustrating how an inadequate CV strategy may easily lead to over optimistic 173 
results. The second one, kBIR-fold CV, was based on the use of biological replicates (BIR) used 174 
to define the different k-fold CV subsets. Finally, the third strategy, CORRS-CV, involved a 175 
repeated constrained random selection of training sets for k-fold CV. 176 
Assessment of the predictive performance 177 
False-colour images showing the distribution of a molecule in the sample can be built by 178 
plotting the intensity of a given m/z value at the pixels coordinates. Similarly, the outcome 179 
from the supervised or unsupervised analysis of the hyperspectral data cubes can be used to 180 
plot false-colour images by projecting information extracted (e.g. predicted class) at each 181 
pixel coordinates. For example, the input (Y) of the predefined classes on a PLS-DA is a 182 
dummy variable (generally +1 and -1) but the output is an unbounded continuous score that 183 
can take any values in the [-∞, +∞] range. Figure 1A shows mean y predicted values by 184 
random 5-fold CV (5 iterations) of the data set (i.e. using 80% of the total sample size for 185 
training each time). Results show an almost perfect classification of cancer and normal 186 
tissues, in agreement with an AUROC-CV = 0.998 (LVs=3). Then, a permutation test was 187 
carried out for significance testing of the CV-figure or merit. Basically, this type of test 188 
measures the likelihood of obtaining an observed classification accuracy by chance[18]. 189 
During a permutation test, new labels are randomly assigned to the observations (e.g. pixels) 190 
and a new classifier is trained and cross validated. The process is repeated a number of times 191 
and the distribution of the accuracy estimates obtained using random class labels is 192 
compared to the accuracy estimate obtained using true class labels. Then, an empirical p-193 
value is calculated as the fraction of values where the classifier provided better classification 194 
performance in the random than in the original data. If the p-value is lower than a user 195 
selected threshold (e.g. 0.05), the null hypothesis that there is no difference between the 196 
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means is rejected and it is assumed that the classifier is significant. The distribution of 197 
AUROC-CV values obtained using randomly permuted class label at the pixel level indicated a 198 
statistically significant classifier performance (p-value<0.05, AUROC-CV range [0.48, 0.53]). 199 
However, it is expected that results presented were overly optimistic if there is a large 200 
redundancy across pixels lying together. On the one hand, a random 5-fold CV may produce 201 
train and test sets containing highly correlated spectra from spatially close pixels, leading to 202 
over optimistic prediction error estimates using true labels. Besides, the strategy selected to 203 
shuffle the class labels should reflect the structure of the data. A random permutation of the 204 
class of each pixel leads to situations in which spatially close pixels are differently labeled, 205 
leading to overly pessimistic performances for permuted models and so, to estimates of the 206 
statistical significance of the true model that were biased in an optimistic way. To avoid this 207 
potential pitfall, a second permutation test involving a random shuffle of the class label of 208 
each of the 16 tissues as a block was carried out. Although in this case, AUROC-CV values 209 
obtained using permuted class label varied in the [0.97, 0.99] range, the obtained p-210 
value<0.05 also indicated a statistically significant classifier performance. The distribution of 211 
AUROC-CV values from permuted models indicated that the random shuffle of the class label 212 
of each of the 16 tissues images provided a more reliable estimation of the statistical 213 
significance and was used for the assessment of kBIR-fold CV and CORRS-CV results. 214 
Figure 1B show y predicted values by kBIR-fold CV. Results showed again a clear difference 215 
between the spectral profiles of cancer and normal tissues, providing an excellent 216 
classification rate (AUROC-CV = 0.985, LVs = 5). The lower AUROC-CV compared to that 217 
estimated by random k-fold CV, supported the hypothesis that random k-fold CV had an 218 
overly optimistic bias. Nonetheless, results from a permutation test also indicated that the 219 
AUROC-CV value estimated by kBIR-fold CV was statistically significant (p-value < 0.05).  220 
CORRS-CV was then used to assess the performance of a PLSDA model to discriminate 221 
cancer from normal tissues. The RCC data includes 16 images of human kidney tissues. 222 
However, each image is a relatively small and the maximum distances between pixels of the 223 
same class within each image are in the 17-41 AU (4.25-10.25 mm) range. One of the 224 
limitations of CORRS-CV is that the size of the training set limits the maximum ∂ values 225 
tested and vice versa[11]. Large ∂ values may lead to ill conditioned training sets formed by 226 
a very limited number of pixels not representative of the entire data set. Besides, the 227 
CORRS-CV algorithm iterates the training set selection and model development until a 228 
percentage of the pixels (99%) is included in, at least, one train and test sets and so, large ∂ 229 
values increase the number of iterations and the computing time.  230 
An initial test was carried out to analyse the effect of ∂and the train size on the CORRS-CV 231 
estimates by testing train sizes and ∂ values in the [100, 200] pixels and [1, 5] AU ranges, 232 
respectively. Figure 2A depicts the obtained AUROC values as a function of the train size and 233 
∂ value. Results showed again an excellent discrimination between both types of tissues 234 
with AUROC values in the 0.970-0.988 range. However, for any train size considered, a 235 
gradual decrease in the AUROC value for test pixels at increasing∂was observed. Besides, 236 
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the classification accuracy was higher for pixels close to a train pixel for any train size 237 
considered (See Figure 2B). These results were in agreement with the hypothesis that the 238 
performance estimates observed by k-fold CV were overly optimistic. 239 
Figure 1C shows the distribution of the y predicted values by CORSS-CV for the test sets, 240 
using a train size of 200 pixels and ∂=4. False color images were comparable to those 241 
obtained by k-fold CV and kBIR-fold CV. It has to be noted that the dataset used represents as 242 
a‘worst case scenario’to show differences in the model performance between standard 243 
CV and CORRS-CV because the differences between control/cancer tissues were highly 244 
significant. Despite this fact, the mean AUROC = 0.982 obtained for the test sets was slightly 245 
higher that the AUROC-CV obtained by kBIR-fold CV and lower than that provided by random 246 
k-fold CV. Moreover, as abovementioned, during CORRS-CV, the discriminant models are 247 
build and selected using training sets in which the minimum distance among pixels is also 248 
higher than a given threshold (i.e. ∂). The accuracy estimates obtained for the train and test 249 
sets were comparable (e.g. mean classification errors for inner-CV and testing sets were 250 
0.052±0.01 and 0.060±0.02, respectively) indicating that the elimination of highly correlated 251 
spectra from spatially close pixels leads to generalizable inner models.  252 
During CORRS-CV that the selection of training sets and model optimization is iterated, 253 
generating a set of predicted values for test pixels. In this work, we used the mean value of 254 
the predicted values, but other alternatives are available. For example, a majority vote using 255 
the classes predicted at each iteration for each testing pixel or the estimation of confidence 256 
intervals for the predicted values could also be applied. 257 
Effect of the sample size 258 
The use of kBIR-fold CV is the most appropriate strategy for CV. However, it has several 259 
drawbacks: it can be inefficient when the number of biological replicates available is scarce, 260 
and also if the different sizes and class distributions of cancer and normal pixels in the 261 
biological replicates are highly unbalanced. To test the differences among random k-fold CV, 262 
kBIR-fold CV and CORRS-CV, Figure 3 shows results obtained using the three CV strategies for 263 
every possible combination of biological replicates using between 3 and 8 images from the 264 
RCC data set. Results showed that repeated random k-fold CV provided the highest CV 265 
classification accuracy estimates for every data size with AUROC-CV ranging between 0.997 266 
and 1.000. kBIR-fold CV provided unstable accuracy estimates for limited data sizes as shown 267 
by AUROC-CV ranging between 0.634 and 0.997. In these cases, kBIR-fold CV estimates of test 268 
error are easily biased because the models build during CV are not as representative as the 269 
model trained on the whole data set and, on the other hand, models typically show a poor 270 
consistency because prediction estimates are highly dependent on the selected training set. 271 
CORRS-CV provided more stable estimates as shown by lower variation observed in the 272 
AUROC values in the [0.982, 0.999] range. CORRS-CV selects train pixels randomly across all 273 
the images and so, the training sets are more representative of the whole data set as they 274 
include signal (and noise) from different images and so, take into account additional sources 275 
of error. For this test, a ∂=2 was used to allow the selection of training set of 200 pixels 276 
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during CORRS-CV in small data sets (2-3 images) in which case higher∂would limit the train 277 
sizes.  278 
 279 
Feature selection 280 
A variety of algorithms have been proposed to interpret observed differences between 281 
classes in MSI and to select discriminant features such as bootstrapping or jack-knifing for 282 
estimating uncertainty in the model coefficients. Among them, Variable Importance in the 283 
Projection (VIP) scores are widely used to select the variables which contribute the most to 284 
the y variance explanation in a PLS-DA model[19]. A VIP threshold value of one is generally 285 
used as a feature selection criterion. In this work, 3 and 5 LVs were selected based on 286 
repeated random 5-fold CV or kBIR-fold CV results, leading to 244 and 243 MS features with 287 
VIP>1 in each model, respectively and 241 commonly selected in both models. Nonetheless, 288 
the type of CV used for model selection may lead to slightly different PLS-DA models and so, 289 
to different VIP score vectors. 290 
CORRS-CV involves a repeated double cross validation in which, after selecting a training set, 291 
an inner PLS-DA model is selected and applied to a test set. The process is iterated providing 292 
a set of PLS-DA models resulting in different feature rankings according to their VIP values. 293 
Therefore, it seems reasonable to combine the information obtained from the set of train 294 
models to provide a more robust feature selection to aid in eliminating false positive 295 
biomarkers. Accordingly, a mean rank product (RP) was calculated as the geometric mean of 296 
the VIP ranks in the set of PLS-DA models. As described by Breitling et al. [20], “the rank 297 
products can be used to sort the features according to the likelihood of observing them so 298 
high on the list of differently expressed features by chance.” Low ranks (i.e. high VIP scores) 299 
consistently obtained in the PLS-DA models build for the different training sets lead to low 300 
mean VIP ranks, thus allowing the identification of the most discriminant features. 301 
Although the rank of the VIP scores and their RPs are useful to sort the relative important of 302 
m/z features, they are not indicative of statistical significance and the selection of a 303 
threshold is essentially arbitrary. To determine the significance level of both, the VIP rank 304 
and the VIP RP obtained for each feature, values obtained in the model build using real class 305 
labels were compared to reference null distributions formed by the set of values found in 306 
the models build during the permutation tests [18]. Features that did not belong to the 307 
distribution of random values (p-value < 0.05) were classified as potential biomarkers. This 308 
strategy lead to three subsets of 27, 26 and 31 features based on k-fold CV, kBIR-fold CV and 309 
CORRS-CV, respectively (see Figure 4), with 13 features commonly selected (m/z 215, 308, 310 
353, 589, 612, 613, 716, 760, 782, 784, 808 and 809). Although CORRS-CV was slightly less 311 
conservative than k-fold CV, the subset included features previously reported to be 312 
associated with characteristic lipid profiles of RCC[15] such as increased intensities of 313 
PS(18:0/20:4) (m/z 810), PI(18:0/20:4) (m/z 886) and PI(22:4/18:0) (m/z 914) and decreased 314 
intensity of FA(12:0) (m/z 215), the latter with the lowest mean VIP rank product.  315 
 316 
9 
4. CONCLUSIONS 317 
Assessment of discriminant models in hyperspectral MSI data sets is challenging and we 318 
always strive to validate at the most conservative level. The preferred strategy is 319 
independent testing, although in cases where the number of samples is limited, CV could be 320 
regarded as a sub-optimal alternative. K-fold CV is one of the most widely used methods for 321 
CV where, as a general rule, data split should be done at the highest level of the sampling 322 
hierarchy (e.g. biological replicate) rather than technical replicates or individual pixels. 323 
However, a low number of biological replicates represents a challenge for CV. Results show 324 
that the use of biological replicates to define k-fold CV split provides an accurate estimation 325 
of the generalization performance, but it is inefficient when the number of biological 326 
replicates is scarce. In these situations where holding images back for testing is a waste of 327 
valuable information, CORRS-CV can be used to reduce, or even eliminate, the overly 328 
optimistic bias due to the use of test pixels close to the training set, providing more accurate 329 
and robust figures of merit. Besides, the use of VIP rank products increases the robustness of 330 
the selection of discriminant features as candidate biomarkers which is an important issue 331 
due to the increased biological, environmental and technical variabilities when analysing 332 
multiple images, especially from human tissues collected in clinical studies. Nonetheless, 333 
several aspects must be taken into account. On the one hand, increasing ∂ limits the 334 
number of training pixels and it might lead to an ill-conditioned trap where the underlying 335 
distribution is not represented in the train data. As the size of the training set and ∂ 336 
determine each other, a trade-off must be ensured, taking into account the image size, the 337 
similarity across spatially close pixels and the total computation time. This study shows the 338 
performance of CORRS-CV involving PLS-DA; however, the method of subset- selection of 339 
training and test sets could potentially be beneficial also in combination with other 340 
algorithms for sample discrimination. 341 
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Figure 1. PLSDA y predicted values by k-fold CV using repeated random 5-fold CV (A), 356 
biological replicates to define the k-fold CV subsets (B) and CORRS-CV (∂: 2, train size: 200 357 





























































































































































Figure 2. AUROC values calculated by CORRS-CV for testing sets (A) and for pixels close to 365 
the training sets (B) excluded from the test sets, as a function of the maximum distance to a 366 





Figure 3. Effect of the number of CRC images on the predicted performance of PLS-DA 372 
models for the discrimination between cancer and normal tissues in the RCC data set. For 373 
each number of images, results using all possible combination of RCC images were calculated 374 
using k-fold CV (green circles), kBIR-fold CV (red circles) and CORRS-CV (yellow circles). NOTE: 375 
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Figure 4. Number of features selected as discriminant based on results obtained by k-fold 387 







Table 1. Number of pixels classified as cancer or normal tissue in each matched pair of 394 








1 297 514 37 9.0 
2 190 204 48 5.7 
3 202 161 56 6.1 
4 409 392 51 12.4 
5 527 229 70 16.0 
6 533 81 87 16.1 
7 351 586 34 10.6 
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The validation of MSI biomarkers is challenging due to correlation among pixels. 
CV based on pixels provide over-optimistic results. 
CV based on biological replicates improves reliability, but it is no viable at small sample sizes. 
CORSSCV provides a suitable alternative, providing trustworthiness to the biomarkers found. 
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